47 related articles for article (PubMed ID: 391257)
1. Applying organ clearance concepts in a clinical setting.
Duconge J
Am J Pharm Educ; 2008 Oct; 72(5):121. PubMed ID: 19214275
[TBL] [Abstract][Full Text] [Related]
2. Interaction between valproic Acid and phenytoin.
Closson RG
West J Med; 1983 Jan; 138(1):108. PubMed ID: 18749266
[No Abstract] [Full Text] [Related]
3. Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.
Rowell FJ; Hui SM; Fairbairn AF; Eccleston D
Br J Clin Pharmacol; 1981 Apr; 11(4):377-82. PubMed ID: 7259931
[TBL] [Abstract][Full Text] [Related]
4. Drug interactions with valproic acid.
Levy RH; Koch KM
Drugs; 1982 Dec; 24(6):543-56. PubMed ID: 6818015
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid and diazepam interaction in vivo.
Dhillon S; Richens A
Br J Clin Pharmacol; 1982 Apr; 13(4):553-60. PubMed ID: 6802161
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant drugs. An update.
Eadie MJ
Drugs; 1984 Apr; 27(4):328-63. PubMed ID: 6327221
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of phenytoin.
Richens A
Clin Pharmacokinet; 1979; 4(3):153-69. PubMed ID: 383353
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions.
Levy RH; Moreland TA
Schweiz Rundsch Med Prax; 1984 Feb; 73(6):159-63. PubMed ID: 6424205
[No Abstract] [Full Text] [Related]
9. Valproic acid: interactions with phenytoin and phenobarbital.
Keys PA
Drug Intell Clin Pharm; 1982 Oct; 16(10):737-9. PubMed ID: 6814881
[No Abstract] [Full Text] [Related]
10. Modification of phenytoin clearance by valproic acid in normal subjects.
Frigo GM; Lecchini S; Gatti G; Perucca E; Crema A
Br J Clin Pharmacol; 1979 Dec; 8(6):553-6. PubMed ID: 391257
[TBL] [Abstract][Full Text] [Related]
11. Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects.
Perucca E; Hebdige S; Frigo GM; Gatti G; Lecchini S; Crema A
Clin Pharmacol Ther; 1980 Dec; 28(6):779-89. PubMed ID: 6777108
[TBL] [Abstract][Full Text] [Related]
12. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
O'Leary TD; Sansom LN
J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
[TBL] [Abstract][Full Text] [Related]
13. Intravenous valproate: effects on plasma and saliva phenytoin levels.
Pisani FD; Di Perri RG
Neurology; 1981 Apr; 31(4):467-70. PubMed ID: 6783979
[TBL] [Abstract][Full Text] [Related]
14. Interactions of valproic acid with phenytoin.
Bruni J; Gallo JM; Lee CS; Perchalski RJ; Wilder BJ
Neurology; 1980 Nov; 30(11):1233-6. PubMed ID: 6775245
[TBL] [Abstract][Full Text] [Related]
15. Effects of sodium valproate on the serum protein binding of phenytoin, and on liver enzyme activity.
Richens A; Makki K; Monks A; Oxley J; Laidlaw J
Monogr Neural Sci; 1980; 5():221-8. PubMed ID: 6798427
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
